Showing results (141-150 of 284) with videos related to
Sort By:
Pageof 29
Obstetrics and Gynecology|December 1, 1986
Central nervous system metastases in epithelial ovarian carcinomaD M Larson, L J Copeland, R P Moser, et al.Gynecologic Oncology|June 1, 1985
Continuous-infusion vinblastine in refractory carcinoma of the cervix: a phase II trialJ J Kavanagh, L J Copeland, D M Gershenson, et al.Gynecologic Oncology|July 1, 1993
Aborted exenterative procedures in recurrent cervical cancerB Miller, M Morris, F Rutledge, et al.Obstetrics and Gynecology|May 1, 1986
Urinary conduits in gynecologic oncologyK C Hancock, L J Copeland, D M Gershenson, et al.Obstetrics and Gynecology|February 1, 1982
Cisplatin chemotherapy for disseminated endometrial cancerJ C Seski, C L Edwards, J Herson, et al.European Journal of Gynaecological Oncology|January 1, 1996
Sarcoma botryoides of the uterine endocervix: long-term results of conservative surgeryO Balat, A Balat, C Verschraegen, et al.Diabetes|July 26, 2000
Transient effects of long-term leptin supplementation in the prevention of diet-induced obesity in miceR S Surwit, C L Edwards, S Murthy, et al.Anticancer Research|January 1, 1997
Existent proliferative responses of peripheral blood mononuclear cells from healthy donors and ovarian cancer patients to HER-2 peptidesB Fisk, J M Hudson, J Kavanagh, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1995
Changes in an HER-2 peptide upregulating HLA-A2 expression affect both conformational epitopes and CTL recognition: implications for optimization of antigen presentation and tumor-specific CTL inductionB Fisk, C Savary, J M Hudson, et al.Gynecologic Oncology|March 1, 1992
Minimally invasive vulvar carcinoma: an indication for conservative surgical therapyJ L Kelley, T W Burke, C Tornos, et al.Pageof 29